Pharmaceuticals Companies By Ebitda

EBITDA
EBITDAEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
1.22 T
 0.00 
 1.38 
 0.00 
2NVO Novo Nordisk AS
137.38 B
(0.11)
 3.85 
(0.44)
3RDY Dr Reddys Laboratories
96.67 B
 0.05 
 1.49 
 0.08 
4MRK Merck Company
25.71 B
 0.05 
 1.89 
 0.10 
5JNJ Johnson Johnson
24.78 B
 0.14 
 1.31 
 0.18 
6NVS Novartis AG ADR
20.71 B
 0.09 
 1.30 
 0.12 
7PFE Pfizer Inc
18.13 B
 0.07 
 1.47 
 0.11 
8AZN AstraZeneca PLC ADR
15.44 B
 0.11 
 1.58 
 0.18 
9LLY Eli Lilly and
15.23 B
 0.03 
 1.92 
 0.05 
10SNY Sanofi ADR
11.03 B
(0.03)
 1.78 
(0.05)
11GSK GlaxoSmithKline PLC ADR
6.67 B
 0.03 
 1.80 
 0.06 
12ZTS Zoetis Inc
3.87 B
(0.09)
 1.57 
(0.15)
13BMY Bristol Myers Squibb
3.17 B
 0.00 
 1.92 
 0.00 
14VTRS Viatris
2.82 B
 0.01 
 1.97 
 0.02 
15OGN Organon Co
1.61 B
(0.02)
 3.05 
(0.07)
16BHC Bausch Health Companies
1.55 B
 0.15 
 2.92 
 0.43 
17ELAN Elanco Animal Health
1.49 B
 0.13 
 1.94 
 0.26 
18JAZZ Jazz Pharmaceuticals PLC
1.37 B
 0.15 
 1.65 
 0.24 
19RPRX Royalty Pharma Plc
1.29 B
 0.18 
 1.30 
 0.24 
20TEVA Teva Pharma Industries
777 M
(0.08)
 2.43 
(0.20)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.